Cargando…
Metabolomics as a Promising Resource Identifying Potential Biomarkers for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a relapsing chronic disorder of the gastrointestinal tract characterized by disruption of epithelial barrier function and excessive immune response to gut microbiota. The lack of biomarkers providing early diagnosis or defining the status of the pathology difficul...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915257/ https://www.ncbi.nlm.nih.gov/pubmed/33562024 http://dx.doi.org/10.3390/jcm10040622 |